Impact of anti-tumor necrosis factor-α agents on serum levels of KL-6 and surfactant protein-D in patients with psoriasis

Influence of Smoking in Interstitial Pneumonia Presenting with a Non-Specific Interstitial Pneumonia Pattern

(2016) Tetsuro Sawata et al.   INTERNAL MEDICINE

Infliximab and adalimumab, unlike ustekinumab, increase serum KL-6 levels in Japanese patients with psoriasis

(2015) Koichi Yanaba et al.   JOURNAL OF DERMATOLOGY

Elevation of serum KL-6 in patients with psoriasis treated with anti-tumour necrosis factor-α therapy

(2014) Y. Higashi et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Elevation of serum KL-6 levels during treatment with tumor necrosis factor-α inhibitor in patients with psoriasis

(2014) Tomotaka Mabuchi et al.   JOURNAL OF DERMATOLOGY

Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality

(2011) J. Hill et al.   EUROPEAN HEART JOURNAL

Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register

(2010) W. G. Dixon et al.   ANNALS OF THE RHEUMATIC DISEASES

Review: Surfactant protein D: A lung specific biomarker in COPD?

(2008) Don D. Sin et al.   Therapeutic Advances in Respiratory Disease